Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Targeted Therapy Market Size Forecast: How Large Could The Market Become By 2030?

The market for targeted therapies has experienced robust expansion lately, projected to climb from 109.99 billion dollars in 2025 to 118.16 billion dollars in 2026, exhibiting a compound annual growth rate of 7.4%. This historical growth trajectory is supported by factors such as the escalating global rates of cancer diagnosis, increased investment in oncology research, the broader utilization of monoclonal antibodies, breakthroughs in molecular biology studies, and a continuous rise in the number of targeted cancer drug approvals.

The market for targeted therapies is poised for significant expansion, projecting a rise to $158.2 billion by 2030, with an anticipated compound annual growth rate of 7.6%. This upward trajectory is fueled by a confluence of factors, including escalating investments in personalized medicine approaches, the burgeoning application of artificial intelligence in drug discovery processes, wider adoption of precision diagnostic tools, a growing preference for cancer treatments with reduced toxicity, and heightened clinical trial endeavors within the field of oncology. Key developments anticipated during this forecast period involve a greater emphasis on developing precision oncology medications, increased utilization of biomarker-guided treatment selection, the broader implementation of combination targeted therapy strategies, expanded use of companion diagnostics, and a more concentrated effort on designing drugs tailored to specific tumor characteristics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

Targeted Therapy Market Industry Drivers: What Is Driving Revenue Growth?

The escalating incidence of cancer is poised to be a significant catalyst for the expansion of the targeted therapy market. Cancer, characterized by the uncontrolled proliferation and invasion of abnormal cells into adjacent tissues, presents a critical healthcare challenge. Targeted therapies offer a sophisticated approach by obstructing the cellular pathways that fuel cancer cell proliferation or by instigating programmed cell death within these malignant cells. These treatments leverage pharmaceuticals designed to precisely identify and neutralize the specific genes and proteins vital for cancer cell propagation and sustenance, thereby augmenting market demand. Illustratively, data from the American Cancer Society indicated a rise in cancer diagnoses to 2,001,140 in January 2024, a notable increase from the 1,958,310 cases reported in 2023, signifying a 2.19% escalation. Consequently, the growing burden of cancer worldwide is anticipated to fuel the advancement and market reach of targeted therapies.

Targeted Therapy Market Segment Outlook: Which Categories Are Expanding The Fastest?

The targeted therapy market covered in this report is segmented –

1) By Type: Small Molecule Medicines, Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

Subsegments:

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

#Targeted Therapy Market Growth Trends: What Is Influencing The Future Outlook?

In the realm of targeted therapy, leading entities are prioritizing collaborative ventures to ensure dependable customer service. A strategic alliance represents a cooperative agreement among several entities, mutually aiding one another to accomplish their individual objectives. As an illustration, in September of 2023, Shine Technologies, a US firm within the pharmaceutical sector specializing in the production of radioactive isotopes for medical use, entered into a collaborative agreement with Curadh MTR Inc., an organization committed to expediting the advancement of molecularly targeted radiation treatments for solid tumors. This particular alliance is geared towards leveraging the capabilities of radioisotopes to accurately identify and eradicate cancerous cells, thereby providing a renewed sense of optimism for patients and revolutionizing the landscape of cancer care.

Targeted Therapy Market Key Companies And Competitive Benchmarking

Major companies operating in the targeted therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

Access The Complete Targeted Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Targeted Therapy Market Geographic Analysis: Where Is Demand Growing The Fastest?

North Americawas the largest region in the targeted therapy market in 2025. The regions covered in the targeted therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model